Logo image of CYB.MI

CYBEROO SPA (CYB.MI) Stock Fundamental Analysis

BIT:CYB - Euronext Milan - IT0005546103 - Common Stock - Currency: EUR

1.455  -0.03 (-2.35%)

Fundamental Rating

7

Overall CYB gets a fundamental rating of 7 out of 10. We evaluated CYB against 65 industry peers in the IT Services industry. CYB scores excellent on profitability, but there are some minor concerns on its financial health. An interesting combination arises when we look at growth and value: CYB is growing strongly while it also seems undervalued. With these ratings, CYB could be worth investigating further for value and growth investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

CYB had positive earnings in the past year.
In the past year CYB had a positive cash flow from operations.
Each year in the past 5 years CYB has been profitable.
Each year in the past 5 years CYB had a positive operating cash flow.
CYB.MI Yearly Net Income VS EBIT VS OCF VS FCFCYB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

The Return On Assets of CYB (9.78%) is better than 92.31% of its industry peers.
The Return On Equity of CYB (17.18%) is better than 76.92% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.37%, CYB belongs to the top of the industry, outperforming 89.23% of the companies in the same industry.
Industry RankSector Rank
ROA 9.78%
ROE 17.18%
ROIC 14.37%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CYB.MI Yearly ROA, ROE, ROICCYB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CYB's Profit Margin of 17.25% is amongst the best of the industry. CYB outperforms 96.92% of its industry peers.
In the last couple of years the Profit Margin of CYB has grown nicely.
With an excellent Operating Margin value of 26.38%, CYB belongs to the best of the industry, outperforming 98.46% of the companies in the same industry.
CYB's Operating Margin has improved in the last couple of years.
CYB has a Gross Margin of 72.96%. This is comparable to the rest of the industry: CYB outperforms 60.00% of its industry peers.
CYB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.38%
PM (TTM) 17.25%
GM 72.96%
OM growth 3Y81.19%
OM growth 5Y6.91%
PM growth 3Y115.04%
PM growth 5Y9%
GM growth 3Y1.43%
GM growth 5Y0.94%
CYB.MI Yearly Profit, Operating, Gross MarginsCYB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CYB is creating some value.
There is no outstanding debt for CYB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CYB.MI Yearly Shares OutstandingCYB.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
CYB.MI Yearly Total Debt VS Total AssetsCYB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

CYB has an Altman-Z score of 3.88. This indicates that CYB is financially healthy and has little risk of bankruptcy at the moment.
CYB has a Altman-Z score of 3.88. This is amongst the best in the industry. CYB outperforms 84.62% of its industry peers.
CYB has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
CYB has a Debt to Equity ratio of 0.24. This is in the better half of the industry: CYB outperforms 67.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 3.88
ROIC/WACC1.71
WACC8.42%
CYB.MI Yearly LT Debt VS Equity VS FCFCYB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

CYB has a Current Ratio of 2.31. This indicates that CYB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CYB (2.31) is better than 90.77% of its industry peers.
CYB has a Quick Ratio of 2.26. This indicates that CYB is financially healthy and has no problem in meeting its short term obligations.
CYB has a better Quick ratio (2.26) than 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 2.26
CYB.MI Yearly Current Assets VS Current LiabilitesCYB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

9

3. Growth

3.1 Past

CYB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.91%, which is quite good.
The Earnings Per Share has been growing by 21.57% on average over the past years. This is a very strong growth
CYB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.10%.
The Revenue has been growing by 32.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)11.91%
EPS 3Y119.81%
EPS 5Y21.57%
EPS Q2Q%29.68%
Revenue 1Y (TTM)14.1%
Revenue growth 3Y37.31%
Revenue growth 5Y32.37%
Sales Q2Q%12.74%

3.2 Future

Based on estimates for the next years, CYB will show a very strong growth in Earnings Per Share. The EPS will grow by 35.40% on average per year.
Based on estimates for the next years, CYB will show a very strong growth in Revenue. The Revenue will grow by 20.76% on average per year.
EPS Next Y39.58%
EPS Next 2Y35.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.83%
Revenue Next 2Y20.76%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CYB.MI Yearly Revenue VS EstimatesCYB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
CYB.MI Yearly EPS VS EstimatesCYB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 0.05 0.1 0.15

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.23, which indicates a correct valuation of CYB.
Compared to the rest of the industry, the Price/Earnings ratio of CYB indicates a rather cheap valuation: CYB is cheaper than 81.54% of the companies listed in the same industry.
CYB's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.79.
Based on the Price/Forward Earnings ratio of 10.75, the valuation of CYB can be described as reasonable.
CYB's Price/Forward Earnings ratio is rather cheap when compared to the industry. CYB is cheaper than 81.54% of the companies in the same industry.
CYB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.23
Fwd PE 10.75
CYB.MI Price Earnings VS Forward Price EarningsCYB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

78.46% of the companies in the same industry are more expensive than CYB, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.51
CYB.MI Per share dataCYB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4 0.5

4.3 Compensation for Growth

CYB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CYB has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CYB's earnings are expected to grow with 35.40% in the coming years.
PEG (NY)0.33
PEG (5Y)0.61
EPS Next 2Y35.4%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CYB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYBEROO SPA

BIT:CYB (4/25/2025, 7:00:00 PM)

1.455

-0.03 (-2.35%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners19.17%
Inst Owner ChangeN/A
Ins Owners4%
Ins Owner ChangeN/A
Market Cap60.27M
Analysts45.71
Price Target3.26 (124.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-31.28%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 13.23
Fwd PE 10.75
P/S 2.83
P/FCF N/A
P/OCF 30.08
P/B 2.82
P/tB 5.6
EV/EBITDA 5.51
EPS(TTM)0.11
EY7.56%
EPS(NY)0.14
Fwd EY9.3%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.05
OCFY3.32%
SpS0.51
BVpS0.52
TBVpS0.26
PEG (NY)0.33
PEG (5Y)0.61
Profitability
Industry RankSector Rank
ROA 9.78%
ROE 17.18%
ROCE 20.96%
ROIC 14.37%
ROICexc 18.09%
ROICexgc 35.34%
OM 26.38%
PM (TTM) 17.25%
GM 72.96%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y81.19%
OM growth 5Y6.91%
PM growth 3Y115.04%
PM growth 5Y9%
GM growth 3Y1.43%
GM growth 5Y0.94%
F-Score5
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA 0.47
Cap/Depr 89.42%
Cap/Sales 22.76%
Interest Coverage 16.11
Cash Conversion 18.16%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 2.26
Altman-Z 3.88
F-Score5
WACC8.42%
ROIC/WACC1.71
Cap/Depr(3y)106.5%
Cap/Depr(5y)137.24%
Cap/Sales(3y)22.88%
Cap/Sales(5y)33.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.91%
EPS 3Y119.81%
EPS 5Y21.57%
EPS Q2Q%29.68%
EPS Next Y39.58%
EPS Next 2Y35.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.1%
Revenue growth 3Y37.31%
Revenue growth 5Y32.37%
Sales Q2Q%12.74%
Revenue Next Year20.83%
Revenue Next 2Y20.76%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.24%
EBIT growth 3Y148.79%
EBIT growth 5Y41.51%
EBIT Next Year100%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-403.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-63.18%
OCF growth 3Y39.87%
OCF growth 5Y27.17%